
Carcinoma of the bladder, which is also known as transitional cell carcinoma, affects the urothelial cells that line the urinary tract- the bladder, the ureters, and a portion of the kidneys. Thus, it becomes the form most commonly associated with the bladder; however, it may also affect other urinary system structures.
Risk Factors:
The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.
The medical treatment for Urothelial Carcinoma requires evaluating the patient's severity and medical condition. The following are the treatment options:
Transurethral Resection of Bladder Tumor (TURBT): minimally invasive surgery for surgically removing superficial tumours from the bladder.
Chemotherapy : It is intravesical for superficial tumours, while systemic (e.g., Gemcitabine and cisplatin) for tumours that have grown into muscle or metastasised.
Cost Start From USD 600 - USD 700Explore Options
Immunotherapy : Checkpoint inhibitors stimulate the immune system to attack cancer cells and are used mainly in advanced or resistant cases to chemotherapy.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation Therapy: Advanced palliative care based on external beam radiation can involve using this radiation either alone or following surgery. The advanced disease can also be treated because symptoms such as bleeding and obstruction require palliative care.
Targeted Therapy and BCG: Targeted medications that aim at specific genetic mutations. However, BCG activates the immune system against non-muscle-invasive bladder cancer, improving outcomes.
Cost Start From USD 8000 - USD 12000Explore Options
These are the standard diagnostic methods for diagnosing Urothelial Carcinoma:
MediRehab (chain of Rehab centres - part of MediGence provides comprehensive rehabilitation services designed to support patients in India. Additional services are as per the patient's requirement. These services include:









Gurugram, India
Sanar International Hospital is a multispeciality hospital based on Golf Course Road in Gurugram, a part of Delhi NCR. It was founded in 2018 and houses one of the most comprehensive and advanced surgical care specialties. This 150-bedded facility is committed to providing the best patient experiences and healthcare services is the core of the hospital’s mission. Staffed by a group of visionary and competent medical professionals who are well-versed in their fields and eminent for their empathy and understanding, Sanar International Hospital provides optimal care to its patients, making it a popular
Specialties in the Hospital such as Heart, Bone, and Joint neurosciences, Cancer, Kidney and Liver Transplant, and other successful procedures along with experienced medical professionals have made a mark for themselves among domestic patients and international patients who come to India to have the finest healthcare services. It follows strict international practices and believes that the centricity of the patient is essential for providing high-quality care through world-class infrastructure and state-of-the-art facilities. The technologies offered by the Hospital include Digital X-rays, MRI, CT, Ultrasound, transfusion medicine, pharmacy, laboratory services, 24 hrs emergency and ambulance services.
It offers more than 20 plus specialties such as General Medicine, Anesthesiology, Cardiac Sciences, Ophthalmology, Gastroenterology, Hematology, Orthopedics, General Surgery & Surgical, Cardiothoracic Surgery, Hepato Biliary Surgery, Pediatrics, Liver Transplantation, and Critical Care Medicine. The Hospital has a highly skilled medical staff of neuro-anesthetists, neurologists, specialized neurocritical care experts, neurosurgeons neuropsychologists, and neuropsychiatrists. There are specific centers for the treatment of epilepsy, stroke, brain tumors, movement disorders, spinal problems, and headaches.

Ghaziabad, India
Founded in 2010, Manipal Hospital-Ghaziabad (formerly Columbia Asia Hospital) is a well-known multispecialty hospital accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH). With 100 beds, the hospital is committed to providing effective and reasonably priced healthcare in a clean and safe setting. The hospital has several departments that are known for their expertise, including Orthopaedics, Internal Medicine, Gastroenterology, Plastic Surgery, Obstetrics and Gynecology, ENT, and more. Due to this recognition, the hospital is now regarded as one of the best medical establishments in the Ghaziabad area.

Ahmedabad, India
Apollo Hospital International Limited located in Ahmedabad, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the much-growing reasons for India being frequented for Urothelial Carcinoma treatment:
Although one cannot prevent the disease, risk factor reduction- for example, quitting smoking, eating good food, staying hydrated, and avoiding chemicals can reduce the possibility of urothelial carcinoma development.
The prognosis is determined by the stage at which the cancer was diagnosed. Late-stage tumours are considered aggressive and associated with a poor prognosis, while early-stage non-muscle-invasive bladder cancer is associated with a reasonable survival rate.
PCPs and immune checkpoint inhibitors support a patient's immune system in recognising and destroying cancer cells in advanced or metastatic urothelial carcinoma cases.
Yes, urothelial carcinoma can recur, particularly in the setting of non-muscle invasive cancers. Follow-up through cystoscopies and urine tests can help detect recurrences as early as possible.
The side effects may change from treatment to treatment. They include fatigue, nausea, hair loss, urinary problems, infections, and immune-mediated side effects (in the case of immunotherapy). Managing side effects is the most critical part of the treatment journey.
Bladder cancer, specifically urothelial carcinoma, is relatively common in India, and there is an increasing incidence mainly because of clearly defined risk factors such as smoking and exposure to environmental toxins. It's among the commonly recorded malignancies of the urinary tract in India.
The probability of survival of patients with urothelial carcinoma correlates with the stage of cancer at diagnosis. Early recognition significantly augments the chances of survival, especially concerning non-muscle invasive bladder cancer. At the same time, advanced stages may confer a lesser survival probability because of being detected late and getting access to advanced treatment facilities in some regions.
In India, it is more common in men than in women. Men aged 50 years and above, especially those with a history of smoking and occupational exposure to chemicals, are at greater risk. However, bladder cancer in women is also on the rise.
Treatment is usually stage-dependent but may vary somewhat based on tumour location. Surgery, chemotherapy, immunotherapy, and sometimes radiation are often used in combinations. These combinations may enhance response to treatment, particularly amongst the advanced cases.